feed,title,long_url,short_url
MedRxiv,"Twelve-month follow-up of immunogenicity and safety of fractional and standard booster doses of the Pfizer-BioNTech COVID-19 vaccine in adults primed with ChAdOx1, BBIBP-CorV, or GAM-CoV-Vac: a randomised controlled trial",https://medrxiv.org/cgi/content/short/2025.08.29.25334703v1?rss=1,
MedRxiv,Tracking Student Wellbeing Throughout the COVID-19 Pandemic,https://medrxiv.org/cgi/content/short/2025.08.29.25334729v1?rss=1,
MedRxiv,Study of SARS-CoV-2 genomes from Pakistan in the post-pandemic period 2023-2024 shows unique phylogenetic diversity as compared with other global data,https://medrxiv.org/cgi/content/short/2025.08.29.25334710v1?rss=1,
